On the 24th of August 2001, a group of business and licensing executives united in Basel and founded the Swiss Pharma Licensing Group. The first Board defined objectives, recruited members and set up the foundation for today’s association.
Financing and Deal-making in turbulent times, 2nd March 2021, 3.00pm – 6.00pm CET
Adapting ongoing clinical trials
Adapting business plans and operations
Industrial association and government resources
Health authority guidelines
Swiss task forces and initiatives
Partnering & collaboration resources
Sales & marketing resources
Scientific materials and tools (reference samples etc)
Diagnostic, Therapeutic & Vaccine developments
Interesting Reads / Literature
The Swiss HLG, a non-profit association of Business Development and Licensing professionals, held its 31st Conference titled “DEAL-MAKING IN THE ROUGH”, in a beautiful setting in the Swiss Alps. The topic of discussion focused on the fact we are living in provoking times: The pharmaceutical and biotech industry as a whole and the professional business developers, alliance managers and dealmakers have to cope with a disruptive and changing environment in which deal making will become more and more complex and ambitious.
Over two and a half days, more than 85 delegates from Switzerland, Europe, the US and Asia gathered in the Swiss Alps to explore and discuss new trends in partnering and deal-making in the current tumult of our industry with the overall objective to capture the maximum value with professional capabilities and high-calibre talents.